covid-19

Fourth COVID-19 vaccine Doses for USA Citizens by FDA

The FDA said Tuesday it has approved a fourth dose of the COVID-19 vaccine for many Americans to protect the most vulnerable situation against serious COVID-19 illness, hospitalization and deaths.

Fourth COVID-19 vaccine Doses for USA Citizens by FDA

According to a news update from the FDA, anyone over the age of Fifty and those over the age of eighteen who have had a stiff organ transplant or are at risk of the same level of immunity are now eligible for a second booster of the Pfizer or Moderna vaccine dose.

“Based on emerging data analysis, a second booster dose of the Pfizer-BioNTech or Moderna COVID-19 vaccine may help increase the level of protection of these high-risk individuals,” said Peter Marks, MD, PhD, director of the FDA’s Center for Biological Evaluation and Research. , Said in the release 6 “Furthermore, data show that an initial booster dose is important to help protect all adults from the potentially serious consequences of COVID-19.”

“So, those who have not received their initial booster dose are strongly encouraged to do so,” he said.

Along with the data submitted by each company, the FDA reviewed and analyzed data from an ongoing study in Israel evaluating the response to a fourth dose prevention among healthcare workers at a healthcare center. All workers received the Pfizer vaccine as their first booster dose. A total of 154 people received a second booster dose with the Pfizer vaccine, while another 120 received a Moderna second booster dose.

covid-19

The fourth dose of covid-19 increased the levels of neutral antibodies against the coronavirus, compared to the human dose 5 months after the first booster dose.

No new security concerns were found or reported in the data.

The FDA says it will continue to analyze or review data on the safety and effectiveness of the second booster dose in other different age groups.